Illumina's Board of Directors authorize a new stock repurchase program

Illumina, Inc. (NASDAQ:ILMN) today announced that its Board of Directors has approved a new stock repurchase program, authorizing the company to repurchase in the aggregate up to $100 million of its outstanding common stock. The $75 million share repurchase program originally announced on August 24, 2009, recently has been completed.

"Considering the strength of our balance sheet and our prospects for continued strong cash generation from our operations, this repurchase program is an effective means to return value to our shareholders," said Jay Flatley, Illumina's president and chief executive officer.

Under the program authorized by the company’s Board of Directors, shares may be purchased either through open market purchases or under a 10b5-1 trading program. The purchases will be funded from existing cash balances.

A trading program under Rule 10b5-1 allows a company to purchase its shares at times when it otherwise might be prevented from doing so under insider trading laws or self-imposed trading blackout periods. A broker selected by Illumina will have the authority under the terms and limitations specified in the plan to repurchase shares on the company's behalf in accordance with the terms of the plan.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Illumina, Inc.. (2019, June 19). Illumina's Board of Directors authorize a new stock repurchase program. News-Medical. Retrieved on May 10, 2024 from https://www.news-medical.net/news/20091125/Illuminas-Board-of-Directors-authorize-a-new-stock-repurchase-program.aspx.

  • MLA

    Illumina, Inc.. "Illumina's Board of Directors authorize a new stock repurchase program". News-Medical. 10 May 2024. <https://www.news-medical.net/news/20091125/Illuminas-Board-of-Directors-authorize-a-new-stock-repurchase-program.aspx>.

  • Chicago

    Illumina, Inc.. "Illumina's Board of Directors authorize a new stock repurchase program". News-Medical. https://www.news-medical.net/news/20091125/Illuminas-Board-of-Directors-authorize-a-new-stock-repurchase-program.aspx. (accessed May 10, 2024).

  • Harvard

    Illumina, Inc.. 2019. Illumina's Board of Directors authorize a new stock repurchase program. News-Medical, viewed 10 May 2024, https://www.news-medical.net/news/20091125/Illuminas-Board-of-Directors-authorize-a-new-stock-repurchase-program.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer